Financial results - MAVIROFARM SRL

Financial Summary - Mavirofarm Srl
Unique identification code: 30691161
Registration number: J18/548/2012
Nace: 4773
Sales - Ron
296.978
Net Profit - Ron
15.092
Employees
6
Open Account
Company Mavirofarm Srl with Fiscal Code 30691161 recorded a turnover of 2024 of 296.978, with a net profit of 15.092 and having an average number of employees of 6. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Mavirofarm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 211.828 239.076 211.763 185.639 398.950 703.496 784.677 846.882 908.253 296.978
Total Income - EUR 213.567 240.229 216.239 188.757 403.578 706.330 786.515 850.577 911.741 345.146
Total Expenses - EUR 190.050 217.180 190.404 183.810 370.401 691.130 771.842 836.096 620.869 327.179
Gross Profit/Loss - EUR 23.517 23.048 25.835 4.947 33.177 15.200 14.673 14.481 290.871 17.967
Net Profit/Loss - EUR 19.754 19.325 22.669 3.080 29.187 8.165 6.807 6.083 245.263 15.092
Employees 4 5 5 4 7 8 9 10 9 6
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -67.1%, from 908.253 euro in the year 2023, to 296.978 euro in 2024. The Net Profit decreased by -228.800 euro, from 245.263 euro in 2023, to 15.092 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Mavirofarm Srl

Rating financiar

Financial Rating -
MAVIROFARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Mavirofarm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Mavirofarm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Mavirofarm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Mavirofarm Srl - CUI 30691161

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 12.217 10.658 8.541 6.078 4.263 26.909 31.666 22.589 15.765 10.998
Current Assets 129.155 160.444 166.752 240.531 401.092 386.928 668.793 414.279 390.606 320.703
Inventories 94.004 118.592 139.232 165.717 315.967 253.018 181.628 210.712 205.224 180.663
Receivables 25.220 5.561 26.221 71.415 77.426 109.337 283.683 98.108 123.449 113.711
Cash 9.931 36.291 1.299 3.400 7.699 24.573 203.482 105.459 61.933 26.329
Shareholders Funds 45.029 63.904 85.500 87.019 114.521 91.889 94.871 9.553 184.748 76.471
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 96.343 107.198 89.793 159.589 290.834 321.947 605.588 427.315 221.624 255.230
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 320.703 euro in 2024 which includes Inventories of 180.663 euro, Receivables of 113.711 euro and cash availability of 26.329 euro.
The company's Equity was valued at 76.471 euro, while total Liabilities amounted to 255.230 euro. Equity decreased by -107.244 euro, from 184.748 euro in 2023, to 76.471 in 2024.

Risk Reports Prices

Reviews - Mavirofarm Srl

Comments - Mavirofarm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.